drugset
drugset / Trial / NCT03488186

PK-PD Comparative Study of Lansoprazole Capsules and Lansoprazole Enteric-coated Capsules in Healthy Chinese Volunteers

NCT03488186 ↗

Phase 1 Completed 24 enrolled First Affiliated Hospital of Zhejiang University Beijing Xuze Medical Technology Co., LTD. · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study was to compare the relative PK-PD of Lansoprazole Capsules and Lansoprazole DR Capsules in healthy Chinese volunteers.

Timeline

Start
2018-07-19
Primary completion
2018-10-11
Completion
2019-04-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Lansoprazole Other / unclassified 30 mg Oral

Indications

No indication recorded.